|
|
||||||||


* Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil, and Institute for Investigation in Immunology (iii), Millenium Institutes, Brazil;
Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil; and
Department of Physiopathology and Experimental Medicine, University of Siena, Siena, Italy
| Abstract |
|---|
|
|
|---|
. Induction of macrophage microbicidal activity by either neutrophils or purified NE required TLR4 expression by macrophages. Injection of purified NE shortly after infection in vivo reduced the burden of L. major in draining lymph nodes of TLR4-sufficient, but not TLR4-deficient mice. These results indicate that NE plays a previously unrecognized protective role in host responses to L. major infection. | Introduction |
|---|
|
|
|---|
production and generation of reactive oxygen species by macrophages (9). Neutrophil elastase (NE)3 is a serine protease released from neutrophil azurophilic granules in inflammatory exudates (11). NE plays a multifaceted role in tissue injury and inflammation, due to its ability to cleave extracellular matrix components and cell surface molecules (12). A specific peptide inhibitor of NE reverts the leishmanicidal activity induced by neutrophils, and exacerbates L. major infection in vivo (9), suggesting a role for NE in macrophage activation. In mammals, TLRs transduce proinflammatory signals delivered by pathogen molecules to the cells of the innate immune system (13). Recent studies indicate that TLRs are involved in immune responses against protozoan parasites (reviewed in Ref. 14). Protective immunity against L. major is impaired in mice deficient of the TLR family adaptor protein MyD88 (15, 16), and signaling through TLR4 contributes to early host resistance against infection (17, 18). In addition, endogenous stimuli initiate inflammatory responses through the engagement of TLRs (19, 20). Specifically, pancreatic elastase induces systemic inflammation and myeloid cell activation through TLR4 (21, 22), and NE induces IL-8 secretion by epithelial cells through activation of TLR4 (23). In this study, we sought to determine the role of NE in the proinflammatory interaction of neutrophils with macrophages infected with L. major. We found that inflammatory neutrophils activated macrophages to kill L. major by a mechanism that required NE and TLR4 signaling. These findings provided new insight into innate protective mechanisms mounted against Leishmania infection.
| Materials and Methods |
|---|
|
|
|---|
BALB/c, C3H/HeN, C3H/HeJ, and C57BL/6J (B6) mice were from Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro. Mutant pallid B6 mice (C57BL/6J-pa) were obtained from University of Siena, Italy, and bred in our facilities. All animal work was approved by an institutional review committee. L. major strain LV39 (MRHO/Sv/59/P) was isolated from the footpads of BALB/c mice, and maintained in vitro (24). Promastigotes were kept for up to 4 wk.
Abs and reagents
Neutralizing anti-TNF-
(clone MP6-XT3) mAb, rat IgG1, rat IgG2a/
, anti-CD16/CD32 mAb, and allophycocyanin-labeled anti-Gr-1 (clone RB6-8C5) mAb were obtained from BD Pharmingen. FITC-labeled Annexin V and propidium iodide were obtained from R&D Systems. Neutralizing anti-TLR4 (clone MTS510), anti-TLR2 (clone T2.5) mAbs, and mouse IgG1/
isotype control were obtained from eBioscience. Abs were used at 10 µg/ml. Purified human NE (Calbiochem; 100–200 ng/ml), Deferoxamine (DFO, 100 µM; Sigma-Aldrich), human recombinant secretory leukocyte protease inhibitor (SLPI, 10–200 ng/ml; R&D Systems), NE inhibitor methoxysuccinyl-Ala-Ala-Pro-Val-chloromethylketone (MeOSuc-AAPV-cmk), and collagenase inhibitor Z-Pro-D-Leu-D-Ala-NHOH (both from Calbiochem, 10 µg/ml) were used. Endotoxin content of purified NE was verified by a quantitative chromogenic Limulus amebocyte lysate kit (QCL-1000 kit, BioWhittaker). In addition, purified NE and LPS (Sigma-Aldrich) were incubated with polymyxin B-agarose affinity chromatography columns with the capacity to retain 10,000 endotoxin units (Detoxi-Gel columns, Pierce).
Exudate neutrophils
Neutrophils were obtained 7 h after i.p. injection of 1 ml of 3% thioglycollate. Exudate cells were washed and incubated in DMEM at 37°C for 1 h in 250 ml flasks (Corning). Recovered nonadherent cells contained 80–90% neutrophils. Apoptotic neutrophils were obtained by overnight incubation ("aging"), as described (25). Aged Gr-1+ cells contained >90% Annexin-V+, propidium iodide-negative cells. Aged cells were extensively washed in cold DMEM before use.
Inflammatory macrophages, infection, and coculture
Macrophages were obtained 4 days after i.p. injection of 1 ml thioglycollate. Exudate cells were plated in 48-well vessels (Nunc). Adherent cells (1 x 105) received 1 x 106 stationary phase L. major promastigotes in complete medium and 10% FCS at 37°C. After 4 h, monolayers were extensively washed. All cultures were done in DMEM (Invitrogen Life Technologies), supplemented with glutamine, 2-ME, gentamicin, sodium pyruvate, MEM nonessential amino acids, HEPES buffer, and 1% v/v Nutridoma-SP (Boehringer Mannheim), instead of FCS. Neutrophils were added at a 10:1 ratio (1 x 106). Cultures were kept for 3 days at 37°C, 7% CO2. Extracellular parasites were absent throughout this period.
Assessment of intracellular load of L. major
After 3 days, monolayers were washed and fed with Schneider medium (Invitrogen Life Technologies) supplemented with 20% FCS and 2% human urine. Monolayers were cultured at 26°C for an additional 3 days. The relative intracellular load of L. major amastigotes was measured by assessing the number of extracellular motile promastigotes produced (26). Profiles of relative parasite loads closely followed the microscopical assessment of the number of amastigotes per 100 macrophages and percentage of infected macrophages (9).
Treatment with elastase and transfer of neutrophils in vivo
Mice were infected with 3 x 106 L. major promastigotes in the hind footpads. After 30 min, mice received 400 ng purified human NE (Calbiochem) in the right hind footpad. Purified NE was passed through polymyxin B columns before injection. In other experiments, mice received 6 x 106 live neutrophils in the right hind footpad instead of NE. After 14 days, parasite loads in right and left draining lymph nodes were separately determined in individual mice by promastigote production in Schneider medium (9).
Cytokine production
Leishmania-infected macrophages (3 x 105) were treated with NE (200 ng/ml), and supernatants were collected after 1–2 days in culture. Supernatants were cleared by centrifugation and assayed for MIP-2 (1-day supernatant) and TNF-
(2-day supernatant) content by sandwich ELISA according to the manufacturers instructions (R&D Systems). Results are the mean and SE of triplicate cultures.
Elastase activity
Elastase enzymatic activity was measured as described (27). Neutrophils (107/ml in serum-free DMEM) were incubated for 4 h at 37°C. Cells were centrifuged to separate into pellet and supernatants. Cell pellets were solubilized in lysis buffer (50 mN Tris (pH 7.4), 1% Triton X-100, 0.25% deoxycholate, 150 mM NaCl, and 1 mM EGTA). For elastase analysis, 20 µl of either supernatant or solubilized pellet were added in triplicate to ELISA plates, followed by 55 µl elastase reaction buffer (0.1 M HEPES, 0.5 M NaCl, 10% dimethylsulfoxide (pH 7.5)). Then, 150 µl of 0.2 mM Elastase substrate I (MeOSuc-AAPV-pna; Calbiochem) was added in reaction buffer, and samples were incubated at 37°C for 1 h. Elastase activity was measured by reading absorbance at 410 nm, using serial dilutions of human elastase (Calbiochem) as standards.
SDS-PAGE and immunoblot analysis
Neutrophils (4 x 107/20 ml in serum-free DMEM) were immediately centrifuged or incubated for 4 h at 37°C, separated into pellet and supernatant and frozen at –70°C. Cell pellets were resuspended in lysis buffer (Invitrogen Life Technologies) with 1% Protease Inhibitor Cocktail set III (Calbiochem) on ice for 30 min. Insoluble material was removed by centrifugation. Supernatants were concentrated by filtration through Centriprep membrane, 3 kDa pore size (Millipore). Protein extracts or concentrated supernatants were boiled and added to each lane. The volume applied per lane was corrected according to the actual proportion of neutrophils, as determined in Giemsa-stained cytospins, to yield the equivalent to 6 x 106 neutrophils. The amount of protein applied to each lane was similar, as determined by Coomassie Blue staining before blotting. Proteins were resolved by SDS-PAGE, transfered to nitrocellulose (Bio-Rad), and subjected to immunoblot analysis. Blocked membranes were incubated with polyclonal Abs to mouse NE (1/200), mouse SLPI (1/200), or mouse
1 antitrypsin (AAT, 1/200; Santa Cruz Biotechnology). Secondary Ab was bovine anti-goat IgG conjugated with HRP (1/1,000), and ECL-Plus detection reagents (Amersham Biosciences) were used to visualize immunoreactive proteins. Gels were calibrated using standard proteins (Santa Cruz Biotechnology) with MW in the range of 23,000 to 132,000 kDa.
Statistical analysis
Data were analyzed by Student t test for independent samples, using SigmaPlot for Windows. Differences with a p value <0.05 were considered significant. For parasite loads in vivo, counts for left and right draining lymph nodes were first normalized by log transformation, and paired t tests were used instead.
| Results |
|---|
|
|
|---|
We have previously demonstrated that the interaction of Leishmania-infected B6 macrophages with live or apoptotic B6 neutrophils is proinflammatory, leading to TNF-
production and TNF-
-dependent killing of intracellular parasites (9). In agreement with previous results (9), we observed that the microbicidal activity induced by apoptotic neutrophils could be prevented by the addition of MeOSuc-AAPV-cmk, a blocker peptide specific for NE (28), but not by a control peptide inhibitory for collagenase (Fig. 1). These results suggested that NE activity is involved in macrophage activation to a leishmanicidal state.
|
The enzymatic activity of NE is regulated by the serpins SLPI and AAT (29, 30). We sought to determine whether unchecked NE proteolytic activity could be responsible for the proinflammatory activity of B6 neutrophils. Analysis by immunoblot did not show any difference between the amounts of expressed SLPI (Fig. 2A) or AAT (data not shown) proteins in BALB/c and B6 inflammatory neutrophils. Furthermore, we found similar amounts of NE in freshly explanted BALB/c and B6 neutrophils (Fig. 2B). However, after 4 h in culture, we found 2–3-fold more NE released into the supernatant of B6, as compared with BALB/c neutrophils (Fig. 2C). This result was reproduced in an additional experiment. To verify whether increased NE secretion resulted in a protease-antiprotease imbalance, we measured the net NE enzymatic activity in the 4-h supernatants. In repeat experiments, NE activity was 2–3-fold higher in B6, compared with BALB/c supernatants (Fig. 2D). These results indicated that, compared with BALB/c neutrophils, B6 neutrophils released increased amounts of net NE enzymatic activity into supernatants.
|
Pallid is a mutation in the protein Pallidin, affecting the biogenesis of lysosome-related organelles by destabilizing the assembly of the biogenesis of lysosome-related organelles complex-1 (31). Mutant pallid B6 mice have reduced coat pigmentation and reduced secretion of lysosomal enzymes in urine (31). In addition, neutrophils from pallid mice release reduced amounts of NE in response to chemotactic stimulus (32). We confirmed that inflammatory neutrophils from pallid mice released reduced amounts of NE into the supernatant, compared with constitutive release from wild-type (WT) B6 neutrophils (Fig. 3A). We sought to determine the outcome of interactions of pallid neutrophils with WT macrophages infected with L. major. Coculture of infected WT macrophages with live WT B6 neutrophils resulted in a dose-dependent reduction of parasite loads in macrophages (Fig. 3B). However, coculture with live pallid neutrophils failed to induce parasite killing, and led to an increase of L. major replication in macrophages at high doses of added neutrophils (Fig. 3C). Culture with dead pallid neutrophils induced parasite killing by macrophages (data not shown), presumably because of leakage of NE into the medium (27). We also tested the effect of adoptive transfer of live neutrophils in vivo on the extent of infection. Transfer of WT B6 neutrophils to the footpads markedly reduced the parasite load in draining lymph nodes of infected B6 mice (Fig. 3D). However, transfer of pallid neutrophils failed to reduce the parasite load of infected B6 mice (Fig. 3E). Taken together, these results suggested a link between NE release, induction of microbicidal activity in macrophages, and a protective effect in vivo.
|
Given the above results, we investigated the effects of purified NE on induction of a microbicidal state in inflammatory macrophages infected with L. major. Initially, we found that the addition of NE at doses of 1 µg/ml or higher induced morphological changes in macrophages, which progressed to cell detachment and death in a proportion of cells. However, at doses of 100–200 ng/ml (3.3–6.6 nM), addition of NE induced dramatic membrane spreading in macrophages, without any sign of cell death (Fig. 4B, compared with Fig. 4A). Macrophage membrane spreading could be prevented by adding the specific NE inhibitor MeOSuc-AAPV-cmk (Fig. 4C). These results indicated that NE protease activity was required for induction of membrane spreading. In addition, they argued against endotoxin contamination as the cause of cell spreading. Addition of purified NE increased the constitutive secretion of the chemokine MIP-2 by infected macrophages (Fig. 5A). Furthermore, addition of purified NE induced intramacrophagic killing of L. major at low dosages, and in a dose-dependent fashion, in B6 macrophages (Fig. 5B). DFO is an iron chelator that prevents oxidative damage (33). The microbicidal activity induced by NE could be reverted by adding DFO (Fig. 5C), or by adding exogenous rSLPI (Fig. 5D). These results suggested that activation of a microbicidal state required production of oxidant species and NE enzymatic activity. The results also argued against any effect of endotoxin contamination.
|
|
production
We investigated whether purified NE induced the secretion of TNF-
by Leishmania-infected macrophages. Similar to apoptotic neutrophils (9), NE induced TNF-
secretion after 48 h (Fig. 6A). Moreover, addition of a neutralizing anti-TNF-
mAb, but not an isotype control, prevented the leishmanicidal activity of purified NE on macrophages (Fig. 6B). These results demonstrated that the leishmanicidal activity of NE depended on TNF-
production by macrophages.
|
Using a chromogenic Limulus assay kit, the purified NE preparations gave undetectable endotoxin levels at a concentration 10–20 times higher than the dosages used in the present study. We further investigated whether removal of any residual endotoxin contamination affected microbicidal activity induced by purified NE. Diluted samples of purified NE or LPS were passed through polymyxin B-agarose columns with the capacity to retain 10,000 endotoxin units. The leishmanicidal activity induced by LPS was lost following passage through polymyxin B-coupled agarose. However, the activity induced by NE was not affected (Fig. 7A). These results confirmed that macrophage activation induced by NE was not due to endotoxin contamination. Secretion of IL-8 induced by NE on epithelial cells requires TLR4 expression (23). We therefore investigated the role of TLR4 in macrophage activation induced by NE. Infected B6 macrophages were treated with purified NE in the presence of neutralizing anti-TLR2 or anti-TLR4 mAbs, or their isotype controls. The neutralizing mAb specific for TLR4, but not for TLR2, prevented the intramacrophagic killing of L. major (Fig. 7B).
|
We investigated the role of TLR4 expression in macrophage interaction with neutrophils. Coculture of inflammatory C3H/HeN neutrophils with C3H/HeN macrophages induced potent leishmanicidal activity (Fig. 7D). However, coculture of the same C3H/HeN neutrophils with TLR4 mutant C3H/HeJ macrophages failed to induce killing, and actually exacerbated the replication of L. major in macrophages (Fig. 7D). These results indicated that TLR4 expression in macrophages was required for the microbicidal activity induced by inflammatory neutrophils. Together, these results indicated that neutrophils and purified NE induced leishmanicidal activity in macrophages through TLR4 signaling.
NE reduced early parasite replication in vivo
We investigated whether injection of purified NE affected in vivo infection by L. major at an early stage. C3H/HeN and C3H/HeJ mice were infected with L. major in both footpads, and NE was injected 30 min later in the right footpad. After 14 days, parasite loads were determined separately in the draining left and right lymph nodes. Except for one of eight animals, NE markedly reduced parasite loads in draining lymph nodes of C3H/HeN mice, but failed to alter the course of early infection in C3H/HeJ mice (Fig. 8). In addition, injection of NE reduced by 3-fold the load of L. major in both infected B6 and BALB/c mice (data not shown). These results indicated that NE restricted L. major infection in vivo, and that this protective effect required TLR4 expression.
|
| Discussion |
|---|
|
|
|---|
by macrophages (9), similar to the replication of Trypanosoma cruzi driven by engulfment of apoptotic lymphocytes (38). In resistant hosts, however, neutrophils protect against early infection in vivo and induce the killing of L. major by macrophages (9). In this study, our results have demonstrated that, in resistant hosts, macrophage activation by inflammatory neutrophils induced the killing of L. major through recruitment of TLR4 by NE.
NE is a serine protease constitutively released by inflammatory neutrophils (11, 12). NE is also released from injured resting blood neutrophils and induces production of TNF-
by human macrophages (26). In agreement with previous studies (9), addition of the NE blocker peptide MeOSuc-AAPV-cmk prevented the ability of B6 neutrophils to induce microbicidal activity in macrophages. Furthermore, administration of MeOSuc-AAPV-cmk to B6 mice at the time of infection with L. major, induces an 8-fold increase of the parasite burden in draining lymph nodes (9). These results suggest a nonredundant role for NE in early defense against L. major infection. Our data now demonstrated a strain-specific polymorphism in the rate of NE released by inflammatory neutrophils. Neutrophils from B6 mice released 2–3 times more NE protein and enzymatic activity into the supernatant, compared with neutrophils from BALB/c mice. The release of myeloperoxidase was also 2–3 times larger in B6 than in BALB/c neutrophils (data not shown). These results suggest that inflammatory B6 neutrophils undergo more extensive degranulation of azurophilic granules compared with neutrophils from BALB/c mice. The increased amount of NE activity released by B6 neutrophils could explain the proinflammatory response induced in macrophages. In agreement with this possibility, inflammatory neutrophils from mutant pallid B6 mice released much less NE than WT neutrophils, failed to activate WT macrophages for killing of L. major, and failed to protect against infection upon transfer in vivo. Similar to neutrophils from BALB/c mice (9), neutrophils from pallid B6 mice exacerbated replication of L. major in vitro. Exacerbated parasite replication could have resulted from the anti-inflammatory clearance of apoptotic neutrophils by macrophages in the absence of simultaneous engagement of a proinflammatory pathway (39, 40). Different from BALB/c neutrophils (9), transfer of pallid neutrophils did not exacerbate the parasite load in vivo. Lack of the deleterious effect could have resulted from either the dose of transfered neutrophils used or from release of serine proteases upon cell transfer.
We investigated the effects of NE on macrophage activation. Addition of purified NE to infected macrophages induced membrane ruffling and cell spreading, up-regulated production of the chemokine MIP-2, and induced intramacrophagic killing of L. major. NE induces oxidant generation in macrophages (41). Our previous studies indicate that the generation of oxygen intermediates, but not NO, is required for microbicidal activity induced by neutrophils (9). In this study, we found that the microbicidal activity of purified NE could be reverted by DFO, suggesting that oxidant generation was required. Microbicidal activity of NE could also be reverted by the serpin SLPI, suggesting that enzymatic activity is required. Previous studies indicate that microbicidal activity of neutrophils requires TNF-
(9), and that purified NE induces TNF-
secretion from human macrophages (27). In agreement, our data indicated that purified NE induced TNF-
secretion in mouse macrophages infected with L. major, and that TNF-
was required for microbicidal activity induced by purified NE.
Signaling through TLRs plays an important role in proinflammatory responses against protozoan parasites (14). In addition, during infection and tissue injury, degradation products of the extracellular matrix function as endogenous ligands of TLRs (19, 20, 21). Injection of pancreatic elastase induces systemic proinflammatory responses through TLR4 (21, 22), and NE induces IL-8 secretion in epithelial cells through engagement of TLR4 (23). In smooth muscle cells, NE induces rapid association of MyD88 with IRAK, followed by NF
B activation (42). These studies suggest that NE activates cell responses through TLRs. We demonstrated that macrophage leishmanicidal activity induced by NE required TLR4. Our results ruled out contamination of NE with LPS, because NE effects on macrophage spreading and microbicidal activity could be reverted by NE blocker peptide, by DFO, and by rSLPI. Using a Limulus lysate assay, endotoxin levels of purified NE were undetectable at doses 10–20 times higher than those used in the present study. Furthermore, the activity of purified NE could not be removed by passage through polymyxin B-coupled agarose. Finally, macrophage activation induced by inflammatory neutrophils also required functional TLR4 expression.
Neutrophils play a protective role against early L. major infection in vivo (9). Furthermore, mice deficient of the TLR family adaptor protein MyD88 develop a nonhealing phenotype upon infection with L. major (15, 16), and protective immunity against L. major is partially impaired in mice deficient of TLR4 (17, 18). Our results have demonstrated that early in vivo administration of NE reduced L. major infection, and that expression of TLR4 was required for this protective effect.
Early engagement of TLR4 mediated by NE triggered a proinflammatory response and induced microbicidal activity. These results contrasted with the notion that phagocytic removal of apoptotic neutrophils is anti-inflammatory (40). However, a recent study demonstrates that B6 macrophages infected with L. major induce neutrophil apoptosis more efficiently than BALB/c macrophages, and that B6 neutrophils are cleared from the site of infection more rapidly than BALB/c neutrophils (43). These findings suggest a mechanism by which proinflammatory neutrophils are rapidly removed from the tissues, helping to resolve inflammation.
Macrophages acquire neutrophil granules from apoptotic neutrophils for antimicrobial activity against Mycobacteria (4, 5, 44). We cannot discard that a similar mechanism induces leishmanicidal activity in the presence of NE. However, if this is the case, both TLR4 and production of TNF-
are critically involved. The molecular mechanism by which NE triggers cellular responses through TLR4 was not determined. NE could cleave extracellular matrix molecules, such as glycosaminoglycans, to generate endogenous ligands for TLRs (20, 21, 45, 46). Alternatively, a direct effect of NE on TLR4 molecules cannot be discarded. Our results could help in the design of new therapeutic approaches against Leishmania infection. In addition, our studies suggested that genetic polymorphisms affecting interactions between macrophages and neutrophils could play a role in innate resistance to Leishmania infection in humans.
| Disclosures |
|---|
|
|
|---|
| Footnotes |
|---|
1 This work was supported by Brazilian National Research Council, Rio de Janeiro State Science Foundation, Programa de Núcleos de Excelência, Institute for Investigation in Immunology, Millenium Institutes, Brazilian Ministry of Science and Technology, John Simon Guggenheim Memorial Foundation, Howard Hughes Medical Institute (Grant 55003669), and by Ministero dell Istruzione, Università e Ricerca, Rome, Italy (Grant 2006069824). ![]()
2 Address correspondence and reprint requests to Dr. George A. DosReis, Programa de Imunobiologia, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde Bloco G, Ilha do Fundão, Rio de Janeiro, Brazil. E-mail address: gdosreis{at}biof.ufrj.br ![]()
3 Abbreviations used in this paper: NE, neutrophil elastase; DFO, deferoxamine; SLPI, secretory leukocyte protease inhibitor; AAT,
1 anti-trypsin; MeOSuc-AAPV-CMK, methoxysuccinyl-Ala-Ala-Pro-Val-chloromethylketone; WT, wild type. ![]()
Received for publication April 10, 2007. Accepted for publication July 16, 2007.
| References |
|---|
|
|
|---|
B. Biochem. Biophys. Res. Commun. 323: 192-196. [Medline]
mediates CTLA-4 suppression of cellular immunity in murine kalaazar. J. Immunol. 164: 2001-2008.
1-antitrypsin in cancer development and progression. Lancet Oncol. 5: 182-190. [Medline]
, PGE-2 and PAF. J. Clin. Invest. 101: 890-898. [Medline]
1 secretion in human airway smooth muscle via NF-
B pathway. Am. J. Respir. Cell Mol. Biol. 35: 407-414. This article has been cited by other articles:
![]() |
A. B. Guimaraes-Costa, M. T. C. Nascimento, G. S. Froment, R. P. P. Soares, F. N. Morgado, F. Conceicao-Silva, and E. M. Saraiva Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps PNAS, April 21, 2009; 106(16): 6748 - 6753. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. F. Tuon, V. S. Amato, H. A. Bacha, T. AlMusawi, M. I. Duarte, and V. Amato Neto Toll-Like Receptors and Leishmaniasis Infect. Immun., March 1, 2008; 76(3): 866 - 872. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |